Attenuated activation of macrophage TLR9 by DNA from virulent mycobacteria.
Alveolar macrophages are the first line of host defence against mycobacteria, but an insufficient host response allows survival of bacteria within macrophages. We aimed to investigate the role of Toll-like receptor 9 (TLR9) activation in macrophage defence against mycobacteria. Human in vitro differentiated macrophages as well as human and mouse alveolar macrophages showed TLR9 mRNA and protein expression. The cells were markedly activated by DNA isolated from attenuated mycobacterial strains (H37Ra and Mycobacterium bovis BCG) as assessed by measuring cytokine expression by real-time PCR, whereas synthetic phosphorothioate-modified oligonucleotides had a much lower potency to activate human macrophages. Intracellular replication of H37Ra was higher in macrophages isolated from TLR9-deficient mice than in macrophages from wild-type mice, whereas H37Rv showed equal survival in cells from wild-type or mutant mice. Increased bacterial survival in mouse macrophages was accompanied by altered cytokine production as determined by Luminex bead assays. In vivo infection experiments also showed differential cytokine production in TLR9-deficient mice compared to wild-type animals. Both human monocyte-derived macrophages as well as human alveolar macrophages showed reduced activation upon treatment with DNA isolated from bacteria from virulent (M. bovis and H37Rv) compared to attenuated mycobacteria. We suggest attenuated TLR9 activation contributes to the insufficient host response against virulent mycobacteria.
Kiemer
Alexandra K
AK
Pharmaceutical Biology, Saarland University, Saarbrücken, Germany. pharm.bio.kiemer@mx.uni-saarland.de
Senaratne
Ryan H
RH
Hoppstädter
Jessica
J
Diesel
Britta
B
Riley
Lee W
LW
Tabeta
Koichi
K
Bauer
Stefan
S
Beutler
Bruce
B
Zuraw
Bruce L
BL
D000818:Animals; D016207:Cytokines / Q000276:immunology; D004269:DNA, Bacterial / Q000276:immunology*; D006801:Humans; D008262:Macrophage Activation / Q000276:immunology*; D016676:Macrophages, Alveolar / Q000276:immunology* / Q000382:microbiology; D051379:Mice; D008817:Mice, Mutant Strains; D009163:Mycobacterium bovis / Q000276:immunology* / Q000472:pathogenicity; D009169:Mycobacterium tuberculosis / Q000276:immunology* / Q000472:pathogenicity; D054735:Phosphorothioate Oligonucleotides / Q000276:immunology; D051217:Toll-Like Receptor 9 / Q000096:biosynthesis* / Q000235:genetics; D014397:Tuberculosis, Pulmonary / Q000276:immunology* / Q000382:microbiology
D016207:Cytokines; D004269:DNA, Bacterial; D054735:Phosphorothioate Oligonucleotides; C495371:TLR9 protein, human; C495370:Tlr9 protein, mouse; D051217:Toll-Like Receptor 9